|
| Status |
Public on Jun 14, 2018 |
| Title |
MET2_2 |
| Sample type |
RNA |
| |
|
| Source name |
human cutaneous squamous cell carcinoma (cSCC) cell line
|
| Organism |
Homo sapiens |
| Characteristics |
metastat: Metastat
immune: Treated with immunosuppressive drugs
replicate: 2
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA was extracted using the RNeasy kit (Qiagen). Quantification and quality control of RNA was performed on a Nanodrop spectrophotometer (Thermo) and Agilent Bioanalyser (Agilent
|
| Label |
biotin
|
| Label protocol |
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
|
| |
|
| Hybridization protocol |
Standard Illumina hybridization protocol
|
| Scan protocol |
Standard Illumina hybridization protocol
|
| Description |
MET2 from a recurrence of MET1
|
| Data processing |
The data were normalised with LUMI in R
|
| |
|
| Submission date |
May 10, 2017 |
| Last update date |
Jun 14, 2018 |
| Contact name |
Ai Nagano |
| Phone |
+44-(0)20 7882 3831
|
| Organization name |
Barts Cancer Institute
|
| Department |
Centre for Molecular Oncology
|
| Lab |
Bioinformatics Unit
|
| Street address |
John Vane Science Centre, Charterhouse Square
|
| City |
London |
| State/province |
--- Select a state --- |
| ZIP/Postal code |
EC1M 6BQ |
| Country |
United Kingdom |
| |
|
| Platform ID |
GPL10558 |
| Series (2) |
| GSE98767 |
Integration of genomic driver events and gene expression profiles in cutaneous squamous cell carcinoma |
| GSE98780 |
The genomic landscape of cutaneous squamous cell carcinoma |
|
